10-year follow-up results of the prospective, double-blinded, randomized, controlled study on autologous bone marrow buffy coat grafting combined with core decompression in patients with avascular necrosis of the femoral head.

ABSTRACT: BACKGROUND:Avascular necrosis of the femoral head (ANFH) is a severely disabling disease of the hip. Several clinical trials have shown promising outcomes on the use of mesenchymal stem cells for the treatment of ANFH, but long-term clinical assessments are lacking. Previously, we reported the 2-year follow-up results of a prospective, double-blinded, randomized, controlled study on autologous bone marrow buffy coat grafting combined with core decompression in patients with ANFH. Here, we report the 10-year follow-up results of this study. METHODS:We recruited 43 (53 hips) patients from 2009 to 2010. The hips were randomly allocated to code decompression (CD) with or without bone marrow buffy coat (BBC) grafting. Participants underwent follow-up at 24, 60, and 120?months postoperatively. The visual analogue scale (VAS), Lequesne algofunctional index, and Western Ontario and McMaster Universities Arthritis Index (WOMAC) osteoarthritis scores were recorded. Survival rate analysis and prognostic factor analysis were performed. The endpoint was defined as progression to Ficat stage IV or conversion to hip arthroplasty. RESULTS:A total of 31 patients (41 hips) were included in the final analysis. The CD + BBC group had better subjective assessment scores than the CD group. The average survival times were 102.3?months and 78.1?months in the CD + BBC group and CD group, respectively (log-rank test, P?=?0.029). In the univariate Cox proportional hazards regression model, age [hazard ratio (HR)?=?1.079, P?=?0.047] and preoperative Ficat stage (HR?=?3.283, P?=?0.028) indicated a high risk for progression, while the use of BBC (HR?=?0.332, P?=?0.042) indicated a low risk. Preoperative Ficat stage III was isolated as an independent risk factor for clinical failure in the multivariate model (HR?=?3.743, P?=?0.018). CONCLUSION:The 10-year follow-up results of this prospective, double-blinded, randomized, controlled study showed that the use of autologous BBC in combination with core decompression was more effective than the use of core decompression alone. TRIAL REGISTRATION:ClinicalTrials.gov, NCT01613612 . Registered on 13 December 2011-retrospectively registered.

SUBMITTER: Li M 

PROVIDER: S-EPMC7364559 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature